Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Yeghiazarians Y, Gaur M, Zhang Y, Sievers RE, Ritner C, Prasad M, Boyle A, Bernstein HS.

Cytotherapy. 2012 Feb;14(2):223-31. doi: 10.3109/14653249.2011.623690. Epub 2011 Oct 31.

2.

[From precursor to reprogrammed cells: evolution of cardiomyoplasty].

Szala S, Matuszczak S, Czapla J, Wiśniewska E.

Postepy Hig Med Dosw (Online). 2014 Feb 4;68:153-61. doi: 10.5604/17322693.1088354. Review. Polish.

3.

Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration.

Kumar D, Kamp TJ, LeWinter MM.

Coron Artery Dis. 2005 Mar;16(2):111-6. Review.

PMID:
15735404
4.

New directions in strategies using cell therapy for heart disease.

Itescu S, Schuster MD, Kocher AA.

J Mol Med (Berl). 2003 May;81(5):288-96. Epub 2003 Apr 16. Review.

PMID:
12698252
5.

Functional properties of human embryonic stem cell-derived cardiomyocytes.

Zeevi-Levin N, Itskovitz-Eldor J, Binah O.

Crit Rev Eukaryot Gene Expr. 2010;20(1):51-9. Review.

PMID:
20528737
6.

Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies.

Zwetsloot PP, Végh AM, Jansen of Lorkeers SJ, van Hout GP, Currie GL, Sena ES, Gremmels H, Buikema JW, Goumans MJ, Macleod MR, Doevendans PA, Chamuleau SA, Sluijter JP.

Circ Res. 2016 Apr 15;118(8):1223-32. doi: 10.1161/CIRCRESAHA.115.307676. Epub 2016 Feb 17. Review.

PMID:
26888636
Items per page

Supplemental Content

Write to the Help Desk